Utilisation of antihyperglycaemic drugs in ten European countries: different developments and different levels-Reference-Cited by-同舟云学术

Utilisation of antihyperglycaemic drugs in ten European countries: different developments and different levels

Published:2006-07-25 Issue:9 Volume:49 Page:2024-2029
ISSN:0012-186X
Container-title:Diabetologia
language:en
Short-container-title:Diabetologia

Author:

Melander A.,Folino-Gallo P.,Walley T.,Schwabe U.,Groop P.-H.,Klaukka T.,Vallano A.,Laporte J.-R.,Gallego M. R.,Schiappa M.,Røder M.,Kampmann J. P.,de Swaef A.,Åberg M.,Månsson N.-O.,Lindblad U.

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00125-006-0331-3.pdf

Reference17 articles.

1. UKPDS Study Group (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837–853

2. UKPDS Study Group (1998) Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 352:854–862

3. Glümer C, Jørgensen T, Borch-Johnsen K (2003) Prevalence of diabetes and impaired glucose tolerance in a Danish population: the Inter99 study. Diabetes Care 26:2335–2340

4. Bitzén P-O, Melander A, Scherstén B, Svensson M, Wåhlin-Boll E (1992) Long-term effects of glipizide on insulin secretion and blood glucose control in patients with non-insulin-dependent diabetes mellitus. Eur J Clin Pharmacol 42:77–83

5. Bergman U, Elmes P, Halse M et al (1975) The measurements of drug comparison. Drugs for diabetes in Northern Ireland, Norway and Sweden. Eur J Clin Pharmacol 8:83–89

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metformin Consumption Trends and the Impact of Adherence on the Consumption of Oral Antihyperglycemic Drugs;International Journal of Innovative Science and Research Technology (IJISRT);2024-06-06

2. Challenges to Lifestyle Medicine for Type 2 Diabetes in Iran: A Synoptic Review;American Journal of Lifestyle Medicine;2023-04-03

3. Quality of care in type 2 diabetes in Iran; a cross-sectional study using patient-level data;BMC Endocrine Disorders;2022-05-17

4. Consumption of antidiabetic medicines in Portugal: results of a temporal data analysis of a thirteen‐year study (2005–2017);BMC Endocrine Disorders;2021-02-24

5. Challenges of managing diabetes in Iran: meta-synthesis of qualitative studies;BMC Health Services Research;2020-06-12